Literature DB >> 26174744

Treatment of drug-induced seizures.

Hsien-Yi Chen1,2,3, Timothy E Albertson1,4, Kent R Olson1,3.   

Abstract

Seizures are a common complication of drug intoxication, and up to 9% of status epilepticus cases are caused by a drug or poison. While the specific drugs associated with drug-induced seizures may vary by geography and change over time, common reported causes include antidepressants, stimulants and antihistamines. Seizures occur generally as a result of inadequate inhibitory influences (e.g., gamma aminobutyric acid, GABA) or excessive excitatory stimulation (e.g. glutamate) although many other neurotransmitters play a role. Most drug-induced seizures are self-limited. However, status epilepticus occurs in up to 10% of cases. Prolonged or recurrent seizures can lead to serious complications and require vigorous supportive care and anticonvulsant drugs. Benzodiazepines are generally accepted as the first line anticonvulsant therapy for drug-induced seizures. If benzodiazepines fail to halt seizures promptly, second line drugs include barbiturates and propofol. If isoniazid poisoning is a possibility, pyridoxine is given. Continuous infusion of one or more anticonvulsants may be required in refractory status epilepticus. There is no role for phenytoin in the treatment of drug-induced seizures. The potential role of ketamine and levetiracetam is promising but not established.
© 2015 The British Pharmacological Society.

Entities:  

Keywords:  anticonvulsants; poisoning; seizures

Mesh:

Substances:

Year:  2015        PMID: 26174744      PMCID: PMC4767205          DOI: 10.1111/bcp.12720

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  74 in total

1.  ED utilization of computed tomography in a poisoned population.

Authors:  Manish M Patel; Ben T Tsutaoka; Shireen Banerji; Paul D Blanc; Kent R Olson
Journal:  Am J Emerg Med       Date:  2002-05       Impact factor: 2.469

2.  Refractory status epilepticus following self-poisoning with the organochlorine pesticide endosulfan.

Authors:  Darren M Roberts; Wasantha Dissanayake; M H Rezvi Sheriff; Michael Eddleston
Journal:  J Clin Neurosci       Date:  2004-09       Impact factor: 1.961

3.  Treatment of pediatric status epilepticus.

Authors:  Tobias Loddenkemper; Howard P Goodkin
Journal:  Curr Treat Options Neurol       Date:  2011-12       Impact factor: 3.598

4.  The distribution of glycine receptors in the human brain. A light microscopic autoradiographic study using [3H]strychnine.

Authors:  A Probst; R Cortés; J M Palacios
Journal:  Neuroscience       Date:  1986       Impact factor: 3.590

5.  A pharmacological study of the depression of spinal neurones by glycine and related amino acids.

Authors:  D R Curtis; L Hösli; G A Johnston
Journal:  Exp Brain Res       Date:  1968       Impact factor: 1.972

6.  Management of star fruit-induced neurotoxicity and seizures in a patient with chronic renal failure.

Authors:  Yu-Chin Lily Wang; Ber-Ming Liu; Robert B Supernaw; Yu-Hong Lu; Ping-Yu Lee
Journal:  Pharmacotherapy       Date:  2006-01       Impact factor: 4.705

7.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

Review 8.  Basis of the antiseizure action of phenytoin.

Authors:  G Tunnicliff
Journal:  Gen Pharmacol       Date:  1996-10

Review 9.  Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology.

Authors:  J H McDonough; T M Shih
Journal:  Neurosci Biobehav Rev       Date:  1997-09       Impact factor: 8.989

10.  Relative efficacy of phenytoin and phenobarbital for the prevention of theophylline-induced seizures in mice.

Authors:  K V Blake; K L Massey; L Hendeles; D Nickerson; A Neims
Journal:  Ann Emerg Med       Date:  1988-10       Impact factor: 5.721

View more
  16 in total

1.  Therapeutics in clinical toxicology: in the absence of strong evidence how do we choose between antidotes, supportive care and masterful inactivity.

Authors:  Geoffrey K Isbister; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2016-03       Impact factor: 4.335

Review 2.  Safety profile of lamotrigine in overdose.

Authors:  Akintunde Alabi; Adam Todd; Andrew Husband; Joe Reilly
Journal:  Ther Adv Psychopharmacol       Date:  2016-08-08

3.  Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.

Authors:  Catheryn D Wilson; Sherrica Tai; Laura Ewing; Jasmine Crane; Taylor Lockhart; Ryochi Fujiwara; Anna Radominska-Pandya; William E Fantegrossi
Journal:  J Pharmacol Exp Ther       Date:  2018-11-12       Impact factor: 4.030

Review 4.  The Potential Proconvulsant Effects of Cannabis: a Scoping Review.

Authors:  Eric E Kaczor; Kevin Greene; Jennifer Zacharia; Laura Tormoehlen; Mark Neavyn; Stephanie Carreiro
Journal:  J Med Toxicol       Date:  2022-03-29

Review 5.  Who gets antidotes? choosing the chosen few.

Authors:  Nicholas A Buckley; Andrew H Dawson; David N Juurlink; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2016-02-17       Impact factor: 4.335

6.  "Herbal seizures"--atypical symptoms after ibogaine intoxication: a case report.

Authors:  Lorenz Breuer; Burkhard S Kasper; Bernd Schwarze; Juergen M Gschossmann; Johannes Kornhuber; Helge H Müller
Journal:  J Med Case Rep       Date:  2015-10-31

7.  Identification of KCC2 Mutations in Human Epilepsy Suggests Strategies for Therapeutic Transporter Modulation.

Authors:  Phan Q Duy; Wyatt B David; Kristopher T Kahle
Journal:  Front Cell Neurosci       Date:  2019-11-15       Impact factor: 5.505

8.  Seizures in an Immunocompetent Adult From Treatment of Latent Tuberculosis Infection: Is Isoniazid to Blame?

Authors:  Bhagyashri Navalkele; Maria X Bueno Rios; John D Wofford; Vijay Kumar; Risa M Webb
Journal:  Open Forum Infect Dis       Date:  2020-04-23       Impact factor: 3.835

9.  Metoprolol treatment of dual cocaine and bupropion cardiovascular and central nervous system toxicity.

Authors:  John R Richards; Jessica B Gould; Erik G Laurin; Timothy E Albertson
Journal:  Clin Exp Emerg Med       Date:  2018-01-31

10.  Molecular docking analysis of timepidium with Acetylcholine and lumacaftor with GABA(A) activator.

Authors:  Warda Ali; Nisar A Shar
Journal:  Bioinformation       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.